|
JP5230865B2
(ja)
|
2004-07-15 |
2013-07-10 |
テトラロジック ファーマシューティカルズ コーポレーション |
Ｉａｐ結合性化合物
|
|
MX2007007195A
(es)
|
2004-12-20 |
2007-10-08 |
Genentech Inc |
Inhibidores de pirrolidina de iap.
|
|
EA012810B1
(ru)
|
2005-02-25 |
2009-12-30 |
Тетралоджик Фармасеутикалс |
Димерные ингибиторы ингибиторов белков апоптоза (iap)
|
|
WO2006122408A1
(en)
|
2005-05-18 |
2006-11-23 |
Aegera Therapeutics Inc. |
Bir domain binding compounds
|
|
AU2006308453B9
(en)
|
2005-10-25 |
2011-12-01 |
Pharmascience Inc. |
IAP BIR domain binding compounds
|
|
WO2007106192A2
(en)
|
2005-12-19 |
2007-09-20 |
Genentech, Inc. |
Inhibitors of iap
|
|
TWI504597B
(zh)
|
2006-03-16 |
2015-10-21 |
Pharmascience Inc |
結合於細胞凋亡抑制蛋白（ｉａｐ）之桿狀病毒ｉａｐ重複序列（ｂｉｒ）區域之化合物
|
|
MX2008012053A
(es)
*
|
2006-03-21 |
2008-12-17 |
Joyant Pharmaceuticals Inc |
Promotores de apoptosis de molecula pequeña.
|
|
BRPI0711591A2
(pt)
|
2006-05-16 |
2011-11-16 |
Aegera Therapeutics, Inc. |
composto de ligação de domìnio bir da iap
|
|
JP5452223B2
(ja)
|
2006-07-24 |
2014-03-26 |
テトラロジック ファーマシューティカルズ コーポレーション |
Ｉａｐ阻害剤
|
|
MX2009000824A
(es)
|
2006-07-24 |
2009-02-04 |
Tetralogic Pharmaceuticals Cor |
Antagonistas dimericos de las proteinas inhibidoras de la apoptosis.
|
|
WO2008014229A2
(en)
*
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
US20100143499A1
(en)
*
|
2006-07-24 |
2010-06-10 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
NZ598890A
(en)
|
2007-04-30 |
2013-10-25 |
Genentech Inc |
Inhibitors of iap
|
|
JP2010528587A
(ja)
*
|
2007-05-07 |
2010-08-26 |
テトラロジック ファーマシューティカルズ コーポレーション |
アポトーシス阻害タンパク質のアンタゴニストに対する感受性のバイオマーカーとしてＴＮＦα遺伝子の発現を用いる方法
|
|
US8835393B2
(en)
|
2008-08-02 |
2014-09-16 |
Genentech, Inc. |
Inhibitors of IAP
|
|
US9394279B2
(en)
|
2009-06-11 |
2016-07-19 |
Abbvie Inc. |
Anti-viral compounds
|
|
US8283372B2
(en)
*
|
2009-07-02 |
2012-10-09 |
Tetralogic Pharmaceuticals Corp. |
2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
|
|
UY32826A
(es)
|
2009-08-04 |
2011-02-28 |
Takeda Pharmaceutical |
Compuestos heterocíclicos
|
|
EP2493879B1
(en)
*
|
2009-10-28 |
2014-05-14 |
Joyant Pharmaceuticals, Inc. |
Dimeric smac mimetics
|
|
AU2010319927B2
(en)
|
2009-10-29 |
2015-01-22 |
Janssen Pharmaceutica Nv |
Alkynyl derivatives useful as DPP-1 inhibitors
|
|
NZ602368A
(en)
|
2010-02-12 |
2014-10-31 |
Pharmascience Inc |
Iap bir domain binding compounds
|
|
UY33236A
(es)
|
2010-02-25 |
2011-09-30 |
Novartis Ag |
Inhibidores dimericos de las iap
|
|
UY33794A
(es)
|
2010-12-13 |
2012-07-31 |
Novartis Ag |
Inhibidores diméricos de las iap
|
|
WO2012083170A1
(en)
*
|
2010-12-16 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
|
US20140163229A1
(en)
*
|
2011-04-07 |
2014-06-12 |
Cornell University |
Silyl monomers capable of multimerizing in an aqueous solution, and methods of using same
|
|
EP2882740B1
(en)
*
|
2012-08-09 |
2017-03-01 |
Bristol-Myers Squibb Company |
Iap antagonists
|
|
PL405505A1
(pl)
*
|
2013-09-30 |
2015-04-13 |
Warszawski Uniwersytet Medyczny |
Zastosowanie pochodnej kwasu diaminodikarboksylowego jako inhibitora aktywności biologicznej IL-15 I IL-2
|
|
RU2685505C1
(ru)
*
|
2018-11-29 |
2019-04-19 |
Михаил Владимирович Овчинников |
Гетероциклические амиды тирозина, обладающие анальгетическим, противовоспалительным и противоотечным действием
|
|
AU2020252216B2
(en)
*
|
2019-04-05 |
2026-02-26 |
Hepagene Therapeutics (HK) Limited |
Bivalent antagonists of inhibitors of apoptosis proteins
|
|
US20230056604A1
(en)
|
2020-01-20 |
2023-02-23 |
Astrazeneca Ab |
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer
|
|
EP4308095A4
(en)
|
2021-03-15 |
2025-02-19 |
Maze Therapeutics, Inc. |
GLYCOGEN SYNTHASE 1 (GYS1) INHIBITORS AND METHODS OF USE THEREOF
|